Use of Clozapine Alongside Chemotherapy in a Treatment-resistant Bipolar Disorder Patient with Ovarian Carcinoma: A Case Report and Brief Review
Overview
Affiliations
Regular monitoring of blood counts ensures the safety of clozapine use; however, certain clinical situations may pose a dilemma for management such as use of clozapine in the presence of myelosuppressive chemotherapy. Further, there is very limited literature to guide such decisions. We report a case of a clozapine-stabilized, treatment-resistant bipolar disorder patient with ovarian carcinoma requiring chemotherapy. The clinical challenges are discussed in light of a brief review of the available reports.
Bipolar Disorder Treatments and Ovarian Cancer: A Systematic Review.
Miniati M, Conversano C, Palagini L, Buccianelli B, Fabrini M, Mancino M Clin Neuropsychiatry. 2021; 17(5):300-313.
PMID: 34909008 PMC: 8629050. DOI: 10.36131/cnfioritieditore20200508.
Challenges in Treating Cancer Patients With Unstable Psychiatric Disorder.
Bellman V, Russell N, Depala K, Dellenbaugh A, Desai S, Vadukapuram R World J Oncol. 2021; 12(5):137-148.
PMID: 34804276 PMC: 8577605. DOI: 10.14740/wjon1402.